Tagged with MEA

Egypt As the largest pharma market in MEA in terms of volume and second only behind Saudi in value, Egypt is an increasingly important part of pharma multinationals’ MEA operations. Here, three regional managers give their takes on what Egypt means to their companies, and their hopes for its future development.…

Egypt Three country managers with a recent experience of bringing new products from their company’s global portfolio into Egypt – and with big plans for more launches in coming years – outline how the product launch process has improved and why government stakeholders are more receptive than ever to industry innovations.…

Egypt Egypt country managers tend not to stay in their roles for more than a few years, instead moving on to different pastures when new opportunities arise. However, those that do stay put – such as Roche’s Mohamed Swilam, now approaching his ninth year as general manager for Egypt – can…

Middle East & Africa General manager of MEA, Khaled Elrefae, explains how Ipsen has strengthened its footprint in the region over the past two years – starting in the UAE and expanding into Saudi Arabia – and in so doing turned MEA into one of its growth centres. As the company plans to increase…

Egypt While evidence and recognition are growing that gender-balanced and diverse management teams at all levels of hierarchies produce positive business outcomes, the MENA region still has a long road to travel in this respect. Only 11 percent of senior management positions in MENA firms and just four percent of board…

Egypt Bristol Myers Squibb’s Oscar Delgado outlines the firm’s successes in bringing innovative medicines to the Middle East and Africa in recent years, how its strategy plays out in an economically diverse region, why partnerships are of vital importance, and the ways in which BMS is participating in Egypt’s healthcare transformation.…

Egypt AbbVie’s GM for Egypt & Levant, Ali Sleiman, explains the factors behind the stellar growth that has made the cluster one of the company’s fastest-growing global markets in 2021. He also discusses the favourable environment created by Egypt’s healthcare reforms and how they have quickened regulatory approvals and access, leading…

Egypt With over 100 years of pharmaceutical industry heritage behind it, EVA Pharma has expanded rapidly in recent years, with a CAGR of 24.39 percent over the last three years, propelling the firm to second place in the overall Egyptian pharma market. CEO Riad Armanious explains why EVA Pharma is intensifying…

Egypt After several years abroad, Mohamed Eldababy recently returned to his home country to become GSK Egypt’s General Manager. Egypt is an important market for GSK as one of the largest multinational employers in the country with over 700 staff and two manufacturing sites. In conversation with PharmaBoardroom, Eldababy shares his…

Saudi Arabia Some of the most significant stories coming out of Saudi Arabia’s dynamic pharmaceutical industry, including Spanish firm Cinfa’s decision to reinforce its presence in the country, how Saudi and other Middle Eastern countries are becoming major importers of Korean biomedical products, and the USD 335 million funding injection secured by…

Egypt BD’s Loay Badr outlines the rationale behind the medtech giant’s recent establishment of a direct presence in Egypt, the significant opportunities for medical device players in the country as it embarks on an ambitious healthcare transformation programme, and how the firm plans to impact and save even more patient lives…

Egypt Boehringer Ingelheim’s Marianne Abou Elkheir, General Manager and Head of Human Pharma for Levant, Iraq and North-East Africa (LINEA) and Sub-Saharan Africa (SSA), walks us through her career trajectory and her experiences in leading pharma and medtech organisations. In addition, she dives into Egypt’s healthcare transformation and trends in the…